Search results
FTC plans to recommend a possible criminal case against ex-Pioneer CEO
Semafor via Yahoo Finance· 14 hours agoAs part of its Exxon deal review, the US agency uncovered comments Scott Sheffield made to Texas...
Apple Vision Pro Sales Slump, Robot Weapons Get Scarier, TikTok Ban Is Here and More
Gizmodo via Yahoo News· 6 days agoThis week Apple got a dose of reality as people are caring less about its Vision Pro. A robot tank...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 2 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
Federal ruling bans non-compete clauses for most workers but rule is challenged in court
Albany Times Union· 5 days agoLabor proponents including the AFL-CIO have long disliked these employment clauses, saying it...
ExxonMobil’s $60bn Pioneer acquisition nears FTC approval
Offshore Technology via Yahoo Finance· 21 hours agoThe US Federal Trade Commission's (FTC) nod is expected following an agreement that Pioneer's...
Exxon Set to Win FTC Approval for $60 Billion Pioneer Deal
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- The US Federal Trade Commission is poised to greenlight Exxon Mobil Corp.’s $60...
Biden administration faces onslaught of lawsuits as business groups claim regulatory overreach
CNBC· 3 days agoWhen the Federal Trade Commission finalized a rule earlier this month banning noncompete clauses,...
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
PYMNTS.com· 10 hours agoThe Federal Trade Commission (FTC) has accused former Pioneer Natural Resources CEO, Scott Sheffield, of allegedly colluding with OPEC officials to manipulate oil output and inflate prices.
US challenges 'bogus' patents on Ozempic, other drugs in effort to spur competition
ABC News· 3 days agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry ...
US challenges ‘bogus’ patents on Ozempic, other drugs to spur competition
Las Vegas Review-Journal· 2 days ago“By filing bogus patent listings, pharma companies block competition and inflate the cost of...